| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.88B | 94.50B | 90.12B | 79.68B | 74.05B | 80.63B |
| Gross Profit | 12.84B | 11.78B | 12.29B | 9.43B | 8.33B | 7.84B |
| EBITDA | 4.30B | 4.14B | 8.74B | 2.33B | 2.24B | 1.94B |
| Net Income | 1.77B | 1.57B | 4.83B | 1.58B | 1.30B | 1.00B |
Balance Sheet | ||||||
| Total Assets | 63.56B | 60.04B | 60.41B | 53.06B | 45.18B | 42.12B |
| Cash, Cash Equivalents and Short-Term Investments | 9.72B | 9.08B | 12.37B | 7.79B | 7.30B | 5.88B |
| Total Debt | 14.86B | 12.96B | 7.28B | 6.98B | 4.29B | 1.48B |
| Total Liabilities | 40.36B | 36.12B | 36.83B | 33.52B | 26.70B | 24.66B |
| Stockholders Equity | 23.20B | 23.92B | 23.58B | 19.54B | 18.48B | 17.45B |
Cash Flow | ||||||
| Free Cash Flow | -711.00M | -3.17B | 5.28B | -22.00M | -1.06B | 2.49B |
| Operating Cash Flow | -621.50M | -2.74B | 6.06B | 700.00M | -389.00M | 3.56B |
| Investing Cash Flow | -364.00M | -1.28B | 2.52B | -1.45B | -654.00M | -98.00M |
| Financing Cash Flow | -816.00M | 419.00M | -4.13B | 1.06B | 2.31B | -1.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥28.31B | 16.22 | ― | 5.33% | -1.45% | -60.63% | |
73 Outperform | ¥26.52B | 9.01 | ― | 5.04% | -2.29% | -41.92% | |
67 Neutral | ¥416.24B | -16.12 | 7.93% | 2.32% | -2.26% | -10.86% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥129.46B | 45.55 | 6.98% | 3.13% | -2.13% | 37.10% | |
49 Neutral | ¥17.67B | 743.26 | ― | 3.24% | -3.73% | -143.19% |